Joel Greenblatt’s Zomedica Corp. ZOM Stock Holding History

Joel Greenblatt’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-149,269	Closed	-$236K	–	1159
2021 Q1	$236K	Buy	+149,269	New	+$244K	0.01%	909

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

KFS

Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Joel Greenblatt's ZOM Position: Q2 2021 in Review

Joel Greenblatt sold out of Zomedica Corp. (ZOM) in Q2 2021, closing a stake of 149,269 shares — an estimated $236K sold.

Joel Greenblatt first reported a position in ZOM in Q1 2021 and held it in 1 quarter. The position peaked at $236K in Q1 2021. 106 funds tracked by Wall St. Rank hold ZOM as of Q2 2021.

Joel Greenblatt reported no remaining Zomedica Corp. position as of Q2 2021 after selling out during the quarter.
Joel Greenblatt sold 149,269 Zomedica Corp. shares in Q2 2021, an estimated $236K.
Joel Greenblatt first reported a position in Zomedica Corp. in Q1 2021 and held it in 1 quarter.
Joel Greenblatt's Zomedica Corp. position peaked at $236K in Q1 2021.
106 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2021.

Based on Gotham Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.